Intermittent reloading attenuates muscle atrophy through modulating Akt/mTOR pathway

Medicine and Science in Sports and Exercise

Volumn 40, Issue 5, 2008, Pages 848-855

  Miyazaki, Mitsunori ^a,b   Noguchi, Miho ^b   Takemasa, Tohru ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Hindlimb unloading; Mafbx; Murfl; Nfkb

Indexed keywords

F BOX PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MUSCLE RING FINGER 1 PROTEIN; PROTEIN KINASE B; UBIQUITIN PROTEIN LIGASE E3; AKT1 PROTEIN, RAT; PROTEIN KINASE;

ARTICLE; BINDING AFFINITY; CONTROL GROUP; CONTROLLED STUDY; EXPERIMENTAL STUDY; HINDLIMB; IMMOBILIZATION; MALE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE MASS; NONHUMAN; PHOSPHORYLATION; PROTEIN BINDING; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; WISTAR RAT; ANALYSIS OF VARIANCE; ANIMAL; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; MALE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; REGENERATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 52149121891     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318163275f     Document Type: Article

References (44)

1. Alessi DR, Andjelkovic M, Caudwell B, et al. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996;15(23):6541-51.
2. Bangart JJ, Widrick JJ, Fitts RH. Effect of intermittent weight bearing on soleus fiber force-velocity-power and force-pCa relationships. J Appl Physiol. 1997;82(6):1905-10.
3. Blough E, Dineen B, Esser K. Extraction of nuclear proteins from striated muscle tissue. Biotechniques. 1999;26(2):202-4, 6.
4. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294(5547):1704-8.
5. Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3(11):1014-9.
6. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell. 1999;96(6):857-68.
7. Cai D, Frantz JD, Tawa NE Jr, et al. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell. 2004;119(2):285-98.
8. Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296(5573): 1655-7.
9. Centner T, Yano J, Kimura E, et al. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. J Mol Biol. 2001;306(4):717-26.
10. Chan TO, Tsichlis PN. PDK2: a complex tail in one Akt. Sci STKE. 2001;2001(66):PEl.
11. Childs TE, Spangenburg EE, Vyas DR, Booth FW. Temporal alterations in protein signaling cascades during recovery from muscle atrophy. Am J Physiol Cell Physiol. 2003;285(2):C391-8.
12. D'Aunno DS, Robinson RR, Smith GS, Thomason DB, Booth FW. Intermittent acceleration as a countermeasure to soleus muscle atrophy. J Appl Physiol. 1992;72(2):428-33.
13. Dehoux MJ, van Beneden RP, Fernandez-Celemin L, Lause PL, Thissen JP. Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Lett. 2003;544(1-3):214-7.
14. Di Giovanni S, Molon A, Broccolini A, et al. Constitutive activation of MAPK cascade in acute quadriplegic myopathy. Ann Neurol. 2004;55(2):195-206.
15. Dupont-Versteegden EE, Knox M, Gurley CM, Houle JD, Peterson CA. Maintenance of muscle mass is not dependent on the calcineurin-NFAT pathway. Am J Physiol Cell Physiol. 2002; 282(6):C1387-95.
16. Glass DJ. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nat Cell Biol. 2003;5(2):87-90.
17. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol. 2005;37(10):1974-84.
18. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc Natl Acad Sci USA. 2001;98(25): 14440-5.
19. Homberger TA, McLoughlin TJ, Leszczynski JK, et al. Seleno-protein- deficient transgenic mice exhibit enhanced exercise-induced muscle growth. J Nutr. 2003;133(10):3091-7.
20. Hu Z, Lee IH, Wang X, et al. PTEN expression contributes to the regulation of muscle protein degradation in diabetes. Diabetes. 2007;56(10):2449-56.
21. Hunter RB, Stevenson E, Koncarevic A, et al. Activation of an alternative NF-kappaB pathway in skeletal muscle during disuse atrophy. FASEB J. 2002;16(6):529-38.
22. Jin B, Li YP. Curcumin prevents lipopolysaccharide-induced atrogin-1/MAFbx upregulation and muscle mass loss. J Cell Biochem. 2007;100(4):960-9.
23. Kamei Y, Miura S, Suzuki M, et al. Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem. 2004;279(39):41114-23.
24. Kandarian SC, Jackman RW. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve. 2006;33(2): 155-65.
25. Koistinen HA, Chibalin AV, Zierath JR. Aberrant p38 mitogen-activated protein kinase signalling in skeletal muscle from type 2 diabetic patients. Diabetologia. 2003;46(10):1324-8.
26. Kubica N, Bolster DR, Farrell PA, Kimball SR, Jefferson LS. Resistance exercise increases muscle protein synthesis and translation of eukaryotic initiation factor 2BepsiIon mRNA in a mammalian target of rapamycin-dependent manner. J Biol Chem. 2005;280(9):7570-80.
27. Ladner KJ, Caligiuri MA, Guttridge DC. Tumor necrosis factor-regulated biphasic activation of NF-kappa B is required for cytokine-induccd loss of skeletal muscle gene products. J Biol Chem. 2003;278(4):2294-303.
28. Latres E, Amini AR, Amini AA. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phos-phatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem. 2005;280(4):2737-44.
29. Lecker SH, Jagoe RT, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004;18(1):39-51
30. Li YP, Chen Y, John J, et al. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atroginl/MAFbx in skeletal muscle. FASEB J. 2005;19(3):362-70.
31. McElhinny AS, Kakinuma K, Sorimachi H, Labeit S, Gregorio CC. Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1. J Cell Biol. 2002;157(1): 125-36.
32. Miyazaki M, Hitomi Y, Kizaki T, et al. Calcineurin-mediated slow-type fiber expression and growth in reloading condition. Med Sci Sports Exerc. 2006;38(6): 1065-72.
33. Obata T, Brown GE, Yaffe MB. MAP kinase pathways activated by stress: the p38 MAPK pathway. Crit Care Med. 2000; 28(4 Suppl.):N67-77.
34. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA. 2002;99(14):9213-8.
35. Reynolds THt, Bodine SC, Lawrence JC Jr. Control of Ser2448 phosphorylation in the mammalian target of rapamycin by insulin and skeletal muscle load. J Biol Chem. 2002;277(20): 17657-62.
36. Rommel C, Bodine SC, Clarke BA, et al. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol. 2001;3(11): 1009-13.
37. Sacheck JM, Hyatt JP, Raffaello A, et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J. 2007;21(1):140-55.
38. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 2004;117(3):399-412.
39. Stitt TN, Drujan D, Clarke BA, et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell. 2004; 14(3):395-403.
40. Thomason DB, Biggs RB, Booth FW. Protein metabolism and beta-myosin heavy-chain mRNA in unweighted soleus muscle. Am J Physiol. 1989;257(2 Pt. 2):R300-5.
41. Thomason DB, Herrick RE, Baldwin KM. Activity influences on soleus muscle myosin during rodent hindlimb suspension. J Appl Physiol. 1987;63(1):138-44.
42. Wan X, Helman LJ. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells Oncogene 2003; 22(50):8205-ll.
43. Williamson D, Gallagher P, Harber M, Hollon C, Trappe S. Mitogen-activated protein kinase (MAPK) pathway activation: effects of age and acute exercise on human skeletal muscle J Physiol. 2003;547(Pt. 3):977-87.
44. Wray CJ, Mammen JM, Hershko DD, Hasselgrcn PO. Sepsis upregulates the gene expression of multiple ubiquitin ligases in skeletal muscle. Int J Biochem Cell Biol. 2003;35(5):698-705.